Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.02M | 5.66M | 5.00M | 4.00M | 4.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.02M | 5.66M | 5.00M | 4.00M | 4.93M |
| Cost of Revenue | 2.20M | 1.94M | 2.38M | 3.36M | 3.34M |
| Gross Profit | 2.82M | 3.72M | 2.62M | 645.80K | 1.59M |
| SG&A Expenses | 3.35M | 3.75M | 3.33M | 7.47M | 3.88M |
| Depreciation & Amortization | 378.20K | 378.00K | 379.40K | 286.20K | 439.10K |
| Other Operating Expenses | 1.88M | 890.60K | 494.50K | -2.75M | 1.11M |
| Total Operating Expenses | 7.82M | 6.96M | 6.59M | 8.37M | 8.78M |
| Operating Income | -2.80M | -1.30M | -1.59M | -4.37M | -3.85M |
| Income Before Tax | -5.92M | -3.40M | -3.24M | -18.48M | -5.47M |
| Income Tax Expenses | -1.40K | 3.60K | 3.70K | 5.30K | 4.60K |
| Earnings from Continuing Operations | -5.92M | -3.41M | -3.25M | -18.48M | -5.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.90K | -9.80K | -10.10K | 34.80K | 7.10K |
| Net Income | -5.91M | -3.42M | -3.26M | -18.45M | -5.47M |
| EBIT | -2.80M | -1.30M | -1.59M | -4.37M | -3.85M |
| EBITDA | -2.42M | -918.00K | -1.21M | -3.92M | -3.41M |
| EPS Basic | -0.06 | -0.03 | -0.03 | -0.19 | -0.06 |
| Normalized Basic EPS | -0.04 | -0.02 | -0.02 | -0.04 | -0.04 |
| EPS Diluted | -0.06 | -0.03 | -0.03 | -0.20 | -0.06 |
| Normalized Diluted EPS | -0.04 | -0.02 | -0.02 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 101.84M | 101.08M | 99.16M | 96.42M | 96.16M |
| Average Diluted Shares Outstanding | 101.84M | 101.08M | 99.16M | 96.42M | 96.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |